Previous 10 | Next 10 |
LAS VEGAS , Sept. 17, 2019 /PRNewswire/ -- GB Sciences, Inc. (OTCQB: GBLX), on Friday, September 13, 2019 , filed an 8k announcing the sale of its 50% ownership stake in GB Sciences Louisiana, LLC. The stake will be purchased by Wellcana Plus LLC, affiliated through its mana...
GB Sciences ( OTCQB:GBLX ) has received notification from the U.S. Drug Enforcement Agency (DEA) that prior to making any decisions on the pending applications, the DEA intends to distribute regulations that govern the program of growing marijuana for scientific research under DEA registra...
LAS VEGAS , Sept. 3, 2019 /PRNewswire/ -- GB Sciences, Inc. (OTCQB: GBLX) today announced that it has received notification from the U.S. Drug Enforcement Agency (DEA) that prior to making any decisions on the pending applications, the DEA intends to distribute regulations that gover...
GB Sciences Names Darin Carpenter as Executive Vice President of Cannabis Operations Canada NewsWire LAS VEGAS, Aug. 28, 2019 LAS VEGAS , Aug. 28, 2019 /CNW/ -- GB Sciences, Inc. (OTCQB: GBLX) today announced the appointment to GB Sciences' executive team of Darin C...
Louisiana is officially the first state in the Deep South to legalize medical marijuana, four long years after lawmakers agreed to give patients access. Despite the delay, medical marijuana patients are happy the day has finally come, as are the pot stocks that are licensed in the state. ...
GB Sciences Prepares To Launch New Products In Louisiana With Educational Seminars For Doctors And Pharmacists Canada NewsWire LAS VEGAS, Aug. 7, 2019 Education program includes evidence-based review of FDA-registered human clinical trial data supporting the use of cann...
History Made! GB Sciences Louisiana Announces Medical Cannabis Products Now for Sale for First Time in State History Canada NewsWire BATON ROUGE, La., Aug. 6, 2019 BATON ROUGE, La. , Aug. 6, 2019 /CNW/ -- GB Sciences Louisiana (OTCQB: GBLX) today announced ...
LAS VEGAS , July 17, 2019 /PRNewswire/ -- GB Sciences, Inc. (OTCQB: GBLX), through its subsidiary, GBS Global Biopharma, Inc. ("GBS", Ottawa, CANADA ), has filed a novel patent application to protect proprietary formulations for chronic pain based on new molecular docking simulations and...
U.S. lawmakers weighed reforming pot laws in what advocates called a "historic” hearing on Wednesday, though there didn't appear to be a clear consensus approach, such as giving states the right for legalization, removing weed from schedule 1 of the Controlled Substances Act, or pro...
Delta, Kelowna, BC - June 11, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today's edition of Investorideas.com potcastsCM - cannabis news and stocks to w...
News, Short Squeeze, Breakout and More Instantly...
LAS VEGAS, Dec. 22, 2022 (GLOBE NEWSWIRE) -- Gb Sciences , Inc. (OTCQB:GBLX), a leading plant-inspired, biopharmaceutical research and development company, is developing cannabis-inspired anti-inflammatory therapeutics that address Cytokine Release Syndrome (CRS) caused by viral infect...
LAS VEGAS, Dec. 12, 2022 (GLOBE NEWSWIRE) -- Gb Sciences , Inc. (OTCQB:GBLX), a leading plant-inspired, biopharmaceutical research and development company, is addressing the growing need for anxiety and depression medications through the development of novel, kava-inspired formulations, which...
LAS VEGAS, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Gb Sciences , Inc. (OTCQB:GBLX), a leading plant-inspired, biopharmaceutical research and drug development company, has co-published a study in the journal Food and Chemical Toxicology that demonstrates the potential of selec...